Aurobindo Pharma clarifies on Zentiva deal; Here’s what it said

Aurobindo Pharma said that Advent International entered into a definitive agreement to sell Zentiva to US-based equity firm GTCR.

Aurobindo Pharma said that Advent International entered into a definitive agreement to sell Zentiva to US-based equity firm GTCR.

Capital goods and public sector shares were the top-performing sectors, while FMCG stocks came under pressure.

Sumeet Abrol, Partner and National Leader – Deals, Grant Thornton Bharat LLP, and Bhavesh Shah of Equirus discuss Indian outbound M&A trends, strategic planning, mid-market participation, global acquisitions, and risk management for corporate growth.

The company also outlined plans to acquire new copper deposits both in India and overseas. It is exploring memoranda of understanding with public sector firms such as RITES, IOCL, Coal India, and GAIL to expand its mining portfolio.

Most large investors are waiting to see a turnaround in corporate earnings before allocating money on Indian stocks.

This strategic expansion marks a significant milestone in MUFG’s commitment to India and its broader Asia Pacific growth strategy, and significantly enhances MUFG’s ability to offer end-to-end financing solutions in India by complementing its well-established leading position in offshore capital…

The order pertains to the supply of Electronic Control Systems used in the Thermal Imaging Fire Control System (TIFCS) for battle-tank applications delivered by Opto Electronics Factory to the Indian Armed Forces, the company informed the stock exchanges.

In a separate exchange filing earlier this week, Mazagon Dock Shipbuilders stated that the company has finally begun negotiations with regards to the P-75I submarine orders, which analysts have cited to be a key trigger for the stock.

Urban Company’s IPO received bids for 243.39 crore shares as against 10.67 crore shares on offer, according to data available as of 12:30 pm.

Over 1 crore shares of JBM Auto have already changed hands compared to the 20-Day average of 1.2 lakh. The stock is now near its 200-DMA of ₹677.